Fundraising FoxDesjardins Capital — 2025 Investments
3 investments dated 2025 · listed companies and verified rows first · show all
Puzzle Medical develops a heart failure treatment device designed to improve heart and kidney function through 4Fr axillary access, allowing patient ambulation and providing up to seven days of support.
HardwareHealthtechMedical DevicesMontreal
Jade Doucet-Martineau(Co-founder & CEO, Board Director)inFrançois Trudeau(Co-founder & CTO, Board Director)inPhilippe Généreux(Co-founder (Phase 2), Chief Medical Officer & Board Observer)inMaxime Rochon(Co-founder (Phase 2) & VP Clinical, Regulatory and Quality)inYves-Antoine Crête(Co-founder (Phase 2) & VP Technical R&D and Operations)inGabriel Georges(Co-founder & Clinical Advisor)in
Co-investorsBroadview VenturesLumira VenturesAjax HealthBoreal VenturesCathexis VenturesFront Row Ventures+3 more
Optable provides a cloud-based platform for identity, audience, and data collaboration that lets publishers, media companies, and advertisers own, enrich, and monetize their first-party data while maintaining privacy.
AdTechData & InfrastructureMarketing TechLos Angeles, US
Yves PoiréinVlad StesininBosko MilekicinWilliam Glasgow Phillips(Executive Officer, Director)
Co-investorsBrightspark VenturesasterXBreakpoint CapitalDeloitte VenturesHearst VenturesMML UK Advisor
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.